Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions

Lee P.-H.Kao Y.-C.Hsieh T.-H.Liao J.-B.Li C.-F.JEN-CHIEH LEEChang Y.-M.Chang C.-D.Huang S.-C.Chen T.-J.Liu T.-T.Yu S.-C.Huang H.-Y.2022-02-142022-02-1420220344-0338https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121221130&doi=10.1016%2fj.prp.2021.153700&partnerID=40&md5=7cbad23b0432e1eeb93b7fefe69dbff1https://scholars.lib.ntu.edu.tw/handle/123456789/594207Aims: Intracranial myxoid mesenchymal tumors (IMMTs) with fusions between EWSR1/FUS and CREB transcription factors have morphologic overlap with myxoid angiomatoid fibrous histiocytoma (mAFH) and myoepithelial tumor/carcinoma (MET/MEC). We aimed to studyAngiomatoid fibrous histiocytoma; CREB; Extracranial; FET; Myoepithelial; Myxocollagenous[SDGs]SDG3adult; aged; Article; cancer growth; cancer recurrence; clinical article; cytoplasm; EWSR1 ATF1 gene; EWSR1 CREB1 gene; EWSR1 CREM gene; female; FUS CREM gene; fusion gene; gene; gene fusion; histiocytoma; human; intracranial myxoid mesenchymal tumor; intMyoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusionsjournal article10.1016/j.prp.2021.153700349296032-s2.0-85121221130